Adam Koppel

Companies

• Kailera Therapeutics, Inc.Board member Apr 16, 2026 to now¹
• Foghorn Therapeutics Inc.Board member Oct 22, 2020 to now²
• Cerevel Therapeutics Holdings, Inc.Board member Oct 29, 2020 to Aug 5, 2024³
• Solid Biosciences Inc.Board member Jan 25, 2018 to Jan 12, 2024⁴
• Aptinyx Inc.Board member Jun 20, 2018 to May 31, 2022⁵
• Dicerna Pharmaceuticals (United States)Board member Apr 13, 2017 to Dec 29, 2021⁶
• BCLS Acquisition Corp.Board member Oct 21, 2020 to Oct 26, 2020⁷
• Replimune Group, Inc.Board member Jul 26, 2018 to Jul 26, 2018⁸
• Trevena IncBoard member Sep 19, 2014 to May 17, 2018⁹
• PTC TherapeuticsBoard member Jun 19, 2013 to Jan 5, 2017¹⁰
• BiogenSVP, Chief Strategy Officer May 15, 2014 to Jun 7, 2016¹¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKailera Therapeutics, Inc. KLRA22,583,268 shares¹²$264.5M at $11.71Apr 20, 2026
• SBSolid Biosciences Inc. SLDB4,034,582 shares¹³$23.3M at $5.77Jan 11, 2024
• DPDicerna Pharmaceuticals (United States)0 shares¹⁴Dec 28, 2021
• CTCerevel Therapeutics Holdings, Inc.0 shares¹⁵Aug 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 20, 2026Bought 1,562,500 shares at $16.00 of Kailera Therapeutics, Inc.¹²
• Apr 20, 2026Converted 4,145,768 shares of Kailera Therapeutics, Inc.¹²
• Apr 20, 2026Converted 16,875,000 shares of Kailera Therapeutics, Inc.¹²
• Aug 1, 2024Returned to company 65,679,781 shares of Cerevel Therapeutics Holdings, Inc.¹⁵
• Aug 1, 2024Returned to company 10,461 shares of Cerevel Therapeutics Holdings, Inc.¹⁵
• Aug 1, 2024Returned to company 3,282 shares of Cerevel Therapeutics Holdings, Inc.¹⁵
• Jun 5, 2024Granted 10,461 shares of Cerevel Therapeutics Holdings, Inc.¹⁶
• Jan 11, 2024Granted 904,160 shares at $5.53 of Solid Biosciences Inc.¹³
• Oct 16, 2023Bought 5,480,052 shares at $22.81 of Cerevel Therapeutics Holdings, Inc.¹⁷
• Jun 7, 2023Other 432,627 shares of Cerevel Therapeutics Holdings, Inc.¹⁸
• Jun 7, 2023Granted 3,282 shares of Cerevel Therapeutics Holdings, Inc.¹⁸
• Dec 28, 2021U 3,080,237 shares at $38.25 of Dicerna Pharmaceuticals (United States)¹⁴
• Dec 28, 2021U 3,333 shares at $38.25 of Dicerna Pharmaceuticals (United States)¹⁴